IFM Due, Inc.
Records under this name other than patents IFM Due, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,618,749 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG In force · High confidence | In force | High confidence | |
| US 12,152,018 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG In force · High confidence | In force | High confidence | |
| US 12,503,436 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG In force · High confidence | In force | High confidence | |
| 17/257,225 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned Sep 18, 2025 | Abandoned | Abandoned Sep 18, 2025 | |
| 17/294,965 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned Jul 19, 2025 | Abandoned | Abandoned Jul 19, 2025 | |
| 17/376,823 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned May 7, 2025 | Abandoned | Abandoned May 7, 2025 | |
| 17/376,829 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned May 8, 2026 | Abandoned | Abandoned May 8, 2026 | |
| 17/422,397 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned Oct 3, 2025 | Abandoned | Abandoned Oct 3, 2025 | |
| 17/610,570 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned Nov 6, 2025 | Abandoned | Abandoned Nov 6, 2025 | |
| 17/618,345 | Compounds and Compositions for Treating Conditions Associated with Sting Activity now held by Novartis Pharma AG Abandoned Abandoned Dec 3, 2025 | Abandoned | Abandoned Dec 3, 2025 |